SEARCH

Current Location: DOTmed News > News Headlines > This Story

Forward Printable StoryPrint Comment

 

More News Headlines

VISITOR AND EXHIBITOR INCREASE AT MEDICAL FAIR INDIA 2014 REFLECTS COUNTRY'S STRONG HEALTHCARE MARKET

VuCOMP M-Vu® Breast Density Version 2.0 Released Automated breast density measurement technology adds critical dimension to the analysis of breast density beyond volume alone: identifying dense tissue in the breast that could mask cancer and taking into account dispersion of fibroglandular tissue.

Toshiba Is First CT Manufacturer to Meet Security Guidelines of the U.S. Department of Defense for Connection to Air Force Network.

Children's Hospital Central California Implements BridgeHead HDM for Rapid Recovery of MEDITECH Data

INFUSION NURSES SOCIETY CITES CHRISTIE EVIDENCE

AHIMA and ICD-10 Coalition Members Urge HHS to Limit ICD-10 Delay to One Year

Isansys wins two SBRI Healthcare development contracts to improve patient safety and reduce risks for cancer patients Isansys' vital signs monitoring platform recognised by NHS England as a leading technology for innovation and change in healthcare delivery.

Claron Showcases Nil Universal Medical Image Viewers at China International Medical Equipment Fair, April 17 to 20

NovoPath Debuts Web Portal for Patient Access to Test Result Reports

Global regulatory affairs specialist ELC Group appoints Localization Business Development Manager for new US Office ELC Group expands delivery of language translation and localization services to North and South American markets with opening of Philadelphia office.

Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND

Newly Improved Peripheral IV Catheter Is Blood-Drawable, Power-Injectable, and Can Deliver Therapy for Entire Length of Stay

SAN DIEGO -- Access Scientific, Inc. announced it has received FDA 510(k) clearance for the 4Fr Nanopuncture™ POWERWAND®. The unique peripheral IV catheter (technically a midline at 3.1 inches) is lighter and designed to provide smoother handling and even greater ease of insertion.

Story Continues Below Advertisement

RISMED Oncology Systems - Linear Accelerator Systems, Parts & Service

RISMED Oncology Systems is one of the most experienced oncology equipment companies with services that can help you from the selection of a site to the daily management of your oncology center. Call 256.585.9881



The 4Fr Nanopuncture POWERWAND is, like the previously FDA-cleared 5Fr version, a power-injectable, peripheral IV catheter that is inserted using the proprietary Accelerated Seldinger Technique.

The POWERWAND can be used both for the administration of fluids/medications and for withdrawing blood for diagnostic tests. It is the first and only power-injectable peripheral IV (PIV) catheter capable of delivering continuous IV therapy for the patient's entire length of hospital stay. The device may be left in place for up to 29 days per its FDA clearance. It is also designed to be an integral part of any program to reduce central-line associated bloodstream infections (CLABSI).

The catheter has been well received by hospitals using it. "The 4Fr version gives the vascular access team more options. An extended-dwell catheter that can be placed both in the upper arm with ultrasound, or in the lower arm or forearm without using ultrasound, is the bridge we needed between the peripheral IV and the PICC. Sometimes with vascular access we need as many options as we can get," said Peter Hobday, RN, CCRN, CRNI, Director of the Vascular Access team at Brotman Medical Center, in Culver City, Calif.

The POWERWAND's versatility makes it the first and best choice for many patients, said Steve Bierman, M.D., president and CEO of Access Scientific.

"CDC Guidelines now say that patients whose IV therapy will likely exceed six days should have a midline or, if -- and only if - indicated, a central line," Dr. Bierman said. "Based on recent studies, this means that nearly 30% of hospitalized patients should have a POWERWAND."

In addition to allowing consistent blood draws, the catheter has a flow rate of 130 mL per minute -- making it by far the fastest-flowing peripheral line of its size. "This rapid flow rate capability translates into lives saved in the emergency department, OR and ICU," said Dr. Bierman.

The POWERWAND has several notable safety features:

* Alternative to central lines. Because it is not a central line, the catheter does not carry the same high risk of potentially fatal bloodstream infections. Midline catheters such as the 4Fr Nanopuncture POWERWAND have the lowest published bloodstream infection rate of all inpatient vascular access devices.

Continue reading Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND...
  Pages: 1 - 2 >>

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED